These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 17138247)

  • 1. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
    Asherson RA; Cervera R
    Autoimmun Rev; 2008 Jan; 7(3):164-7. PubMed ID: 18190872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
    Asherson RA; Espinosa G; Cervera R; Gómez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martínez-González AL; Ingelmo M; Reverter JC; Font J; Triplett DA
    Ann Rheum Dis; 2005 Jun; 64(6):943-6. PubMed ID: 15897312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.
    Asherson RA; Pierangeli S; Cervera R
    J Rheumatol; 2007 Sep; 34(9):1793-5. PubMed ID: 17787048
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hematologic manifestations of the antiphospholipid syndrome.
    Uthman I; Godeau B; Taher A; Khamashta M
    Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association.
    de Carvalho JF; Freitas CA; Lima IV; Leite CC; Lage LV
    Lupus; 2009 Aug; 18(9):841-4. PubMed ID: 19578110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
    Espinosa G; Bucciarelli S; Cervera R; Gómez-Puerta JA; Font J
    Autoimmun Rev; 2006 Dec; 6(2):68-71. PubMed ID: 17138245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome].
    Umibe T; Nawata Y; Mori N; Kanai H; Takabayashi K; Iwamoto I; Yoshida S; Tomioka H
    Ryumachi; 1994 Dec; 34(6):981-7. PubMed ID: 7863389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiphospholipid syndrome and the kidney diseases].
    Majdan M
    Pol Merkur Lekarski; 2010 May; 28(167):341-4. PubMed ID: 20568393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
    Asherson RA
    Immunobiology; 2005; 210(10):727-33. PubMed ID: 16325490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catastrophic APS in the context of other thrombotic microangiopathies.
    Rodríguez-Pintó I; Espinosa G; Cervera R
    Curr Rheumatol Rep; 2015 Jan; 17(1):482. PubMed ID: 25604575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
    Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
    Espinosa G; Bucciarelli S; Cervera R; Lozano M; Reverter JC; de la Red G; Gil V; Ingelmo M; Font J; Asherson RA
    Ann Rheum Dis; 2004 Jun; 63(6):730-6. PubMed ID: 15140782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation].
    Grinberg AR; Heller PG; Correa G; Sarano JF; Molinas FC; Nicastro MA; Alvarez CL
    Medicina (B Aires); 1999; 59(6):743-6. PubMed ID: 10752219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
    Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
    Lupus; 2011 Feb; 20(2):174-81. PubMed ID: 21303834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.